Last year Bayer started settling many of the 13,000 or more cases filed over Yaz side effects. However, until recently, only those patients who suffered blood clot injuries have received compensation.
Now, DrugRisk has learned that Bayer will set aside a settlement fund of $24 million to try to resolve as many as 8,000 outstanding claims from women who allege they suffered gallbladder disease or removal after using Yaz or Yasmin.
Unfortunately, the average payout for victims will only amount to $2,000 to $3,000, with much of that going to cover attorneys fees or doctor bills. However, the settlements will give closure to many who have had an open case for years.
At this time, DrugRisk does not know of any law firms taking new claims for Yaz gallbladder injury. Anyone who has already retained a lawyer for this type of claim is urged to contact them for an update on the settlement.
At the same time, Bayer continues to pay substantially more to settle claims from women who suffered blood clots while taking Yaz or Yasmin. In their latest financial reports, the company admits spending almost $1 billion so far to settle around 4,800 claims for deep vein thrombosis (DVT) or pulmonary embolism. The average settlement for these claims is over $208,000.
Lawyers are still helping those who suffered a blood clot, DVT, stroke or pulmonary embolism after taking Yaz or Yasmin file claims. If you or a loved one have been affected, it is important to speak with a lawyer quickly, as time is limited.
Since federal MDL drug injury cases can be very specialized, DrugRisk only recommends lawyers and law firms who have already settled Yaz lawsuits.
For more information on Yaz blood clots, or to speak with a lawyer, contact us today.